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Knockoutembryos homozygous for a gene trap insertion in the ﬁbulin-1 (Fbln1) gene are
deﬁcient in Fbln1 and exhibit cardiac ventricular wall thinning and ventricular septal defects with double
outlet right ventricle or overriding aorta. Fbln1 nulls also display anomalies of aortic arch arteries, hypoplasia
of the thymus and thyroid, underdeveloped skull bones, malformations of cranial nerves and hemorrhagic
blood vessels in the head and neck. The spectrum of malformations is consistent with Fbln1 inﬂuencing
neural crest cell (NCC)-dependent development of these tissues. This is supported by evidence that Fbln1
expression is associated with streams of cranial NCCs migrating adjacent to rhombomeres 2–7 and that
Fbln1-deﬁcient embryos display patterning anomalies of NCCs forming cranial nerves IX and X, which derive
from rhombomeres 6 and 7. Additionally, Fbln1-deﬁcient embryos show increased apoptosis in areas
populated by NCCs derived from rhombomeres 4, 6 and 7. Based on these ﬁndings, it is concluded that Fbln1
is required for the directed migration and survival of cranial NCCs contributing to the development of
pharyngeal glands, craniofacial skeleton, cranial nerves, aortic arch arteries, cardiac outﬂow tract and
cephalic blood vessels.
© 2008 Elsevier Inc. All rights reserved.IntroductionFibulin-1 (Fbln1) is the ﬁrst described member of a seven-gene
family of extracellular matrix (ECM) proteins that have a common
structural signature consisting of a series of repeated EGF-like
domains followed by a C-terminal element referred to as a ‘ﬁbulin
module’ (Argraves et al., 2003; Chu and Tsuda, 2004). Alternative
splicing produces two Fbln1 variants in nematodes, chickens andmice
and four variant polypeptides in humans. These variants differ at their
C-termini and appear to have distinct biological activities based on
their ability to differentially bind ECMproteins (Sasaki et al., 1995) and
growth factors (Brooke et al., 2002; Perbal et al., 1999) and associate
with distinct networks in the ECM (Muriel et al., 2006).
A major function ascribed to Fbln1 is regulation of cell motility and
guidance. During Caenorhabditis elegans development, Fbln1 is
required for proper guidance of migrating distal tip cells engaged in
gonad morphogenesis (Kubota et al., 2004; Kubota and Nishiwaki,l rights reserved.2003). In Fbln1-deﬁcient nematode embryos, an abnormal widening
of sheets of gonadal cells occurs combined with a failure of distal tip
cells to complete their normal migration to the midline of the animal
(Hesselson et al., 2004). Based on ﬁndings from in vitro studies, Fbln1
can suppress the motility (i.e., migration velocity and persistence
time) of many types of cancer cells (Hayashido et al., 1998; Lee et al.,
2005; Qing et al., 1997; Twal et al., 2001). However, Fbln1 alone is
apparently neither adhesive nor motility suppressive, but acts to
suppress the motility promoting activity of other ECM proteins
including ﬁbronectin (FN) (Twal et al., 2001), one of its principal
binding proteins (Balbona et al., 1992). Evidence that Fbln1 can inhibit
motility promoting activity of other matrix proteins stems from its
ability to inhibit the migration of cells through Matrigel (Qing et al.,
1997), a basement membrane protein rich extract that lacks FN. This
ﬁnding is consistent with the requirement for Fbln1 in regulation of
distal tip cell guidance in C. elegans, a species whose genome does not
encode FN and whose ECM is basement membrane-like (Kramer,
1997).
During vertebrate development, Fbln1 has been indirectly impli-
cated as a regulator of cell motility based on the fact that it is
expressed in association with migrating mesenchymal cells including
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1996; Kern et al., 2006; Spence et al., 1992; Zhang et al., 1995; Zhang et
al., 1993). A number of Fbln1-binding ECM components including FN,
versican, perlecan and laminin α5 have been implicated in the
regulation of embryonic cell motility, particularly in themigration and
guidance of cranial NCCs (Bronner-Fraser, 1993; Perris and Perissi-
notto, 2000). For example, in mice deﬁcient in laminin α5 there are
abnormalities in the migration of NCCs from rhombomeres 6 and 7.
This results in improper condensation of the NCC primordia that give
rise to cranial nerves IX and X (Coles et al., 2006). Similarly, deﬁciency
of integrin β1, a subunit of integrins which bind both laminin α5 and
FN (Kikkawa et al., 2000), leads to defective NCC migration from
rhombomeres 6 and 7 and abnormal formation of cranial nerves IX
and X (Pietri et al., 2004). Loss of ECM constituents that regulate NCCs
can also result in cardiac defects. For example, deﬁciency in perlecan, a
hyaluronan (HA) binding proteoglycan implicated in NCC migration,
leads to increased numbers of mesenchymal cells in the cardiac
outﬂow tract (OFT) and transposition of the great arteries (Costell et
al., 2002). By contrast, increased expression of the proteoglycan
versican, a known inhibitor of NCC migration (Dutt et al., 2006),
correlates with a decrease in NCCs lateral to the neural tube and in the
pharyngeal arches 4 and 6 of Pax 3 mutants (Henderson et al., 1997).
These mutants exhibit a failure of OFT septation owing to insufﬁcient
numbers of NCCs in the OFT (Conway et al., 1997).
Here we report that mouse embryos deﬁcient in Fbln1 display
abnormalities of the OFT, cardiac septa, aortic arch arteries, phar-
yngeal glands, skull bones, cranial nerves and blood vessels of the
head and neck. These and other ﬁndings presented support the
conclusion that Fbln1 plays an important role in the process of NCC
guidance and survival required for proper morphogenesis of cranial
neural crest-derived structures.
Materials and methods
Generation of Fbln1 gene trap mutant mice
To develop a Fbln1-deﬁcient mouse strainwe used an ES cell line, XST011 (parental
cell line E14Tg2a.4 derived from 129P2/OlaHsd strain), which has a gene trap insertion
in the Fbln1 gene (Skarnes et al., 1995; Stryke et al., 2003) (Bay Genomics, San Francisco,
CA). The inserted gene trap element is comprised of a strong splice acceptor, a CD4
transmembrane domain, a β-galactosidase (β-gal) cassette and a neomycin resistance
cassette (Neo). By inclusion of a CD4 transmembrane domain upstream from the β-gal
element, the truncated Fbln1-CD4-β-gal fusion protein is targeted for insertion into the
endoplasmic reticulum (ER) in a type I conﬁguration such that it is retained tethered to
the ER membrane with the β-gal domain facing the cytosol (Skarnes et al., 1995). The
XST011 ES cells were injected into C57BL/6 blastocysts that were then transferred to
foster mothers to obtain chimeric mice. Two germ line competent male chimeras were
generated and bred with C57BL/6 mice.
Genotyping
The genotypes of offspring were determined from tail clip genomic DNA by PCR
using three primers. To detect the wild-type Fbln1 allele, PCR was performed using
Fbln1 primers, 5′-AGCCCCAGCTGATTCTGAACTCCTGACC-3′ (residues 71058–71085 in
GI: 15591330) and 5′-GCAACAGCAGTGTTGGGTGGAGGAAGGG-3′ (residues 71366–
71339 in GI: 15591330). To detect homozygotes, the latter primer was used with a
CD4 primer, 5′-CTCCTACATAGTTGGCAGTGTTTGGG-3′ (residues 743–768 from plasmid
pGT2TMPFS, Bay Genomics). Cycling parameters for PCR were: 39 cycles of 95 °C for
50 s, 53 °C for 30 s and 72 °C for 2 min. The expected size for the amplicon produced
from the wild-type allele is 308 bp. The expected size for the amplicon produced from
the targeted Fbln1 allele is 414 bp.
RT-PCR
To conﬁrm that embryos homozygous for the gene trap insertion were deﬁcient in
each of the twomouse Fbln1 splice variants, Fbln1C and D, PCRwas performed on cDNA
from E9.5 embryos using a sense strand primer, 5′-CCCAATGGCCGCAACTGCCAAGA-
CATTG-3′ (GI: 13938048 Fbln1 and Fbln1 GI: 396820) and two antisense strand primers,
5′-GCCCTCCTCATTGCCAGCGGTGATGGC-3′ (residues 1960–1934 in GI: 13938048) and
5′- GGAGTCTCGAAGGTTCCCTTCTGTGATG-3′ (residues 2061–2034 in GI: 396820).
Cycling parameters for PCR were: 30 cycles of 95 °C for 30 s, 60 °C for 30 s and 72 °C
for 1 min. The expected size for the C-speciﬁc amplicon was 332 bp and the expected
size for the D-speciﬁc amplicon was 380 bp.Mapping of the gene trap insertion element within the mouse Fbln1 gene
To map the position of the gene trap insertion element within intron 14, a series of
forward primers were designed based on sequence from Fbln1 intron 14 and used in
PCR together with an antisense primer 5′-GGTCCCATCACCTCACAGGTCAAAG-3′
(derived from the insertion cassette sequence in pGT2TMPFS). Ampliﬁed products
were cloned and sequenced to identify the insertion site.
To determine the consequence of the gene trap insertion on Fbln1 mRNA splicing,
RT-PCR analysis was performed using RNA isolated from E9.5 heterozygous embryos. A
Fbln1 sense strand primer 5′-CCTCATCTGGCTACAGGCTAGCTCCC-3 (residues 1658–
1683 GI: 396820) and a CD4 antisense strand primer 5′-GGTCCCATCACCTCACAGGT-
CAAAG-3′ (residues 1167–1143 GI: 7304952) were used to generate a fragment that
contains the junctional region between Fbln1 and the CD4 transmembrane region. The
deduced amino acid sequence of the resulting 500 bp fragment is presented as
Supplementary information (Supplementary Fig. 2).
Histology and immunohistochemistry
Embryos were harvested from pregnant females following matings of mice
heterozygous for the Fbln1 gene trap insertion. A piece of the yolk sac was isolated for
genotyping. Embryos were ﬁxed in phosphate buffered saline (PBS) containing 4%
paraformaldehyde and then embedded in parafﬁn and sectioned at 5 μm thickness.
Immunohistochemical staining was performed on deparafﬁnized and rehydrated
sections subjected to antigen unmasking using a high temperature citric acid protocol
(H-3300, Vector Laboratories Burlingame, CA). Sections were incubated with rabbit
anti-Fbln1 (15 μg/ml) (Argraves et al., 1990), anti-Crabp1 (1:100, Abcam, Cambridge,
MA), anti-α-sarcomeric actin (1:500 ascites ﬂuid, Sigma Chemical Corp, St. Louis,
MO), anti-Pax3 (5 μg/ml, Developmental Studies Hybridoma Bank (DSHB) The
University of Iowa, Department of Biological Sciences, Iowa City, IA) or anti-α-
smooth muscle actin (5 μg/ml, Sigma). For mouse monoclonal anti-Fbln1 (3A11) (Tran
et al., 1997) immunolabeling, a proteinase K treatment (20 μg/ml in PBS) was used in
place of the citric acid procedure. Bound antibodies were detected with ﬂuorescently
conjugated secondary antibodies (Jackson Laboratories, Bar Harbor, ME). Nuclei were
labeled with 1 μg/ml propidium iodide (Molecular Probes, Invitrogen Corp., Carlsbad,
CA) in PBS for 5 min prior to a ﬁnal series of washes in PBS. Sections were analyzed
using a Leica TCS SP2 AOBS Confocal Microscope System (Leica Microsystems Inc.,
Exton, PA). Hematoxylin and eosin (H&E) staining was performed using standard
procedures. Alizarin red/Alcian blue staining was performed on whole mounts as
described (Kimmel and Trammell, 1981). TUNEL-based apoptosis analysis was
performed on embryo sections using the ApopTag system (Chemicon International,
Temecula, CA).
Neuroﬁlament antibody labeling was performed on E10.5 whole mount embryos
incubated for 12 h with PBS containing 1% fetal bovine serum (FBS, Atlantic Biologicals,
Lawrenceville, GA), 1% Triton X-100 (PBS/FBS/Triton) with 0.1%H2O2. The embryos were
washed with PBS/FBS/Triton for 4 h and incubated with 0.4 μg/ml neuroﬁlament-M
monoclonal antibody 2H3 in PBS/FBS/Triton. The monoclonal antibody 2H3, developed
by Drs. Jessell and Dodd, was obtained from the DSHB. After washing the embryos were
incubated with anti-mouse-HRP (GE Biosciences, Piscataway, NJ) and the chromogenic
substrate DAB (Pierce, Rockford, IL).
Whole heart confocal imaging by cardiac endopainting
Whole heart confocal imaging was performed using a modiﬁcation of the
endocardial painting procedure described by Miller et al. (Miller et al., 2005). Brieﬂy,
timed pregnant mice of Fbln1 heterozygous intercross matings were dissected and
embryos harvested in PBS containing heparin (1000 U/ml). Embryos (E17.5) were
bisected in the abdomen to allow perfusion through the hepatic sinus with heparin-
containing relaxation buffer (PBS, 1% lidocaine) using pulled glass needles. Hearts were
then perfused with 0.05% FITC-poly-L-lysine (Sigma), which binds the endothelium of
vessels and internal heart structures. The embryos were ﬁxed in 4% paraformaldehyde
for 2 h. Hearts were removed from the thoracic cavity and mounted in a precise frontal
plane (Miller et al., 2005). Dehydration was performed prior to incubation in Murray's
clear. Hearts were examined by confocal microscopy using the 5× objective in 25 μm
optical sections over a total depth of 800 μm.
In situ hybridization
Whole-mount in situ hybridization of E8.3–10.5 embryos was performed using
antisense riboprobes for Fbln1, Sox-10 and Crabp1. cDNA inserts corresponding to each
of these genes were generated using the following primer pairs:
5′-CCAAATCAGATGGCTAACCAGCACAGGGAC-3′ and 5′-ACTGGAAGCTTCCGGG-
GATGTTGATG-3′ for Fbln1, (GI: 6753821); 5′-CCAGGGTGTTTGGTGGTGAGGA-3′ and 5′-
CAGCTCAGTCAGGGCTTGGCCT-3′ for Sox10 (GI: 94399599); and 5′-AACGCAGCGTGC-
GACCGCTCCGCAGC-3′ and 5′-CCCCTCAAGAAGTGTCTGTGTGCAG-3′ for Crabp1 (GI:
7304974). The resulting cDNA were subcloned into pCRII (Invitrogen) and used as
templates to generate digoxigenin-labeled antisense riboprobes. Whole-mount in situ
hybridizations were carried out essentially according to methods described in Hogan et
al. (1994). DIG-labeled antisense RNA probes were detected by BCIP/NBT substrate
(Roche, Indianapolis, IN).
Fig. 2. Embryos homozygous for the Fbln1 gene trap insertion have no immunologically
detectable Fbln1. Panels A and B, 8 M urea extracts from wild-type embryos (+/+),
embryos heterozygous (+/−) and homozygous (−/−) for the Fbln1 gene trap insertion
(E13.5) were subjected to immunoblot analysis using polyclonal antibodies to Fbln1 (A)
and FN (B). Panels C and D, anti-Fbln1 (green) and anti-α-sarcomeric actin (blue)
immunolabeling of tissue sections containing embryonic hearts from wild-type (+/+)
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Embryos were ﬁxed in 4% paraformaldehyde/PBS for 1 h followed by a 12 h
incubation in PBS containing 0.02% sodium deoxycholate and 0.01% NP-40 at 4 °C. To
detect β-gal activity, embryos were incubated in PBS containing 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl2 and 1 mg/ml 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-gal; Pierce), for 1–4 h at 37 °C. The embryos
were then transferred to buffered formalin for 1 h and then stored in PBS with 0.02%
sodium azide.
Fbln1 exon 1 deletion mouse
The mouse strain described by Kostka et al. (2001) carrying a targeted deletion of
Fbln1 exon 1 (on a mixed C57BL/6 and 129/Sv background) was provided by Dr. Mon-
Li Chu (Thomas Jefferson University). Mice were genotyped using the following primer
pairs: 5′-TCACGTGACTTTCTGCCTGT-3′ and 5′-CTGGGTGGGGACCTAGTG-3′ for detecting
the wild-type Fbln1 allele and 5′-GTCTCTGAGCTTTGCGCTCT-3′ and 5′-TAAAGCG-
CATGCTCCAGACTGC-3′ for detecting the allele containing the Fbln1 exon 1 deletion.
Results
Fbln1 gene disruption by gene trap insertion
Mapping of the gene trap insertion element within the mouse
Fbln1 gene (Fig. 1A) revealed that the start of the element was at
position 71146 (GI: 15591330) within intron 14 (Fig. 1B and
Supplementary Fig. 1 for the sequence of the 5′ junction region of
the insertion within intron 14).
To determine the effect of the gene trap insertion on splicing of the
Fbln1 transcript, RT-PCR was performed using a primer from exon 13
and a primer from the CD4 component of the gene trap element. DNA
sequencing of the resulting amplicon revealed that the gene trap
insertion caused an aberrant splicing of exon 14 to the splice acceptor
site of the gene trap cassette. The mis-spliced mRNA encoded the ﬁrst
568 amino acids of the Fbln1 protein in-frame with the CD4
transmembrane containing segment and β-gal element (Supplemen-
tary Fig. 2). Additional RT-PCR analysis showed that embryos (E9.5)
homozygous for the gene trap insertion lacked transcripts encodingFig. 1. Disruption of the Fbln1 gene by gene trap insertion. Panel A shows the
arrangement of the exons and introns in the mouse Fbln1 gene. The exons that encode
the alternatively spliced portions of Fbln1C and D transcripts are connected by lines.
Panel B shows the location of the gene trap element within intron 14 and the
consequential aberrant splicing of exon 14 to the splice acceptor site (SA) of the gene
trap element. Panel C, PCR genotyping of DNA isolated from a wild-type (+/+) embryo
and embryos heterozygous (+/−) and homozygous (−/−) for the Fbln1 allele containing
the gene trap element. Panel D, RT-PCR analysis of RNA isolated from a wild-type
embryo (+/+) and embryos heterozygous (+/−) and homozygous (−/−) for the gene trap
insertion. In panel D, the larger product corresponds to the amplicon produced from the
Fbln1D transcript and the smaller product from Fbln1C mRNA. CD4, CD4 transmem-
brane domain; β-gal, β-galactosidase element.
embryos (C) and embryos homozygous for the Fbln1 gene trap insertion (−/−) (D)
(E10.5). Nuclei were stained using propidium iodide (red). A, atrium; V, ventricle; OFT,
outﬂow tract. Panels E and F, monoclonal Fbln1 antibody 3A11 immunolabeling of tissue
sections containing pharyngeal arch of wild-type E10.5 embryo (E) and an E10.5 embryo
homozygous for the Fbln1 gene trap insertion (−/−) (F). The epitope for monoclonal
antibody 3A11, which has been mapped to amino acid residues 30–153 of Fbln1, is
contained within the Fbln1-CD4-β-gal fusion protein expressed in Fbln1 gene trap
mutants since the fusion protein contains the ﬁrst 568 amino acid residues of the Fbln1
polypeptide. Nuclei were stained using propidium iodide (red). Bar in panel C=150 μm
and also applies to panel D. Bar in panel E=10 μm and applies to panel F.exons located downstream from the insertion element (i.e., exons 15–
18) (Fig. 1D). These ﬁndings indicate that homozygous embryos lack
Fbln1C and D transcripts.
To assess the effects of the gene trap insertion on in vivo Fbln1
protein expression, immunoblot and immunohistological analyses
were performed. By immunoblot analysis using a Fbln1 polyclonal
antibody there was no immunoreactive Fbln1 polypeptide in 8 M urea
extracts from embryos homozygous for the Fbln1 gene trap insertion
(Fig. 2A). Heterozygous embryos showed approximately half the level
of Fbln1 present in wild-type embryos extracts.
Embryonic heart tissue sections from wild-type embryos and
embryos homozygous for the Fbln1 gene trap insertion (E10.5) were
next evaluated by immunohistochemistry. In wild-type embryos,
Fbln1 staining is prominent in the ECM surrounding mesenchymal
cells of the AV and OFT cushions (Fig. 2C). By contrast, no Fbln1
staining was evident in these tissues (Fig. 2D) or any other tissues
examined from Fbln1 gene trap mutants (data not shown). Using a
recombinant amino terminal fragment of mouse Fbln1 (amino acid
residues 1–568), we conﬁrmed that the polyclonal antibody used in
immunohistochemistry and immunoblotting was reactive with the
truncated portion of Fbln1 in the Fbln1-CD4-β-gal fusion protein
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analysis using a Fbln1 monoclonal antibody directed to an amino
terminal epitope contained in the Fbln1-CD4-β-gal fusion protein
(Tran et al., 1997). Pronounced Fbln1 staining was evident in the
wild-type tissues (E10.5) (Fig. 2E), but extremely low levels were
detectable in tissues of embryos homozygous for the gene trap (Fig.
2F). Furthermore, the low levels of immunoreactive material
appeared as discrete intracellular foci. Based on these ﬁndings, it
can be concluded that the Fbln1-CD4-β-gal fusion protein becomes
quantitatively degraded similar to what has been described in mice
homozygous for other genes containing secretory gene trap inser-
tions (Schymeinsky et al., 2002; Zhou et al., 2004). Taken together,
the ﬁndings indicate that embryos homozygous for the Fbln1 gene
trap insertion are effectively Fbln1-deﬁcient.
Lethality occurs in embryos homozygous for the Fbln1 gene trap
insertion
Genotypic analysis was performed on 117 offspring from hetero-
zygous matings. As a result, 37 wild-type, 80 heterozygous and 0
homozygous offspring were detected (Supplementary Table 1). This
non-Mendelian ratio indicated that lethality was occurring in off-
spring homozygous for the gene trap insertion. To determine the stage
of lethality, retrograde genotypic analysis was performed on embryos
from timed heterozygous matings. From E9.5–18.5, homozygous
embryos were detected at a frequency in accordance with Mendelian
expectations (Supplementary Table 1). These ﬁndings indicated that
homozygous embryos were dying at birth. When litters were
examined immediately after birth, null embryos were observed that
were hemorrhagic and either dead or experiencing labored breathing.
Fbln1−/− embryos have blood vessel and lung anomalies
Morphological analysis revealed that homozygous embryos exhibit
bleeding within the eyes and petechial bleeding in the head and neckFig. 3. Mice homozygous for the Fbln1 gene trap insertion display a hemorrhagic
phenotype. Panel A shows E15.5 embryos heterozygous (+/−) and homozygous (−/−) for
the Fbln1 gene disruption. Panels B and C, high magniﬁcation views of the facial regions
of the homozygous and heterozygous embryos shown in panel A. Note blood ﬁlled eye
(B) and petechial bleeding in head, neck and proximal portion of the forelimb and fewer
superﬁcial blood vessels apparent in the mutant embryo. Panels D and E, H&E stained
sections of eyes from E15.5 embryos heterozygous (D) and homozygous (E) for the Fbln1
gene trap insertion. Asterisks indicate the hyaloid cavity. Arrow indicates blood cell
accumulation in the hyaloid cavity. Bar in panel A=1 mm. Bar in panel B=700 μm and
also applies to panel C. Bar in D=200 μm and also applies to panel E.
Fig. 4. Fbln1−/− hearts have DORV, VSD and aortic arch artery abnormalities. Shown are
confocal images of whole mount E17.5 hearts perfused with FITC-poly-L-lysine (green).
Panels A and C are single optical sections from hearts of embryos heterozygous for the
Fbln1 gene trap insertion (+/−). Panels B and D are single optical sections from embryos
homozygous for the Fbln1 gene trap insertion (−/−). A DORV and VSD (arrow) are
apparent in panel B. AVSD (arrow) is also apparent in panel D. In the heterozygous heart
(A), the pulmonary leaﬂets are located dorsal to the aortic leaﬂets (175 μm apart)
whereas in the homozygous heart (B), the aortic and pulmonary leaﬂets appear near the
same focal plane. The later conﬁguration is consistent with a failure in the rotation of
the aorta and pulmonary valve sites during OFT remodeling. Panels E and G, optical
sections from hearts of embryos heterozygous for the Fbln1 gene trap insertion. Panels F
and H, optical sections from embryos homozygous for the Fbln1 gene trap insertion. In
panel F, the right subclavian artery (RSA) is absent from the brachiocephalic artery
(BCA). Panel E is derived from a collapsed z-series of multiple optical sections spanning
950 μm. Panels F–H are single optical sections. Arrow in H points to a constriction of the
right common carotid (RCC). Brackets in panel G and H indicate the width of the aorta
(Ao) lumen. The purple color is the result of the merger of the auto-ﬂuorescence from
543 nm and 633 nm excitation. LV, left ventricle, RV, right ventricle; PA, pulmonary
artery; LCC, left common carotid. Bars in panels A and E=600 μm and apply to panels A–
F. Bar in panel G=150 μm and also applies to panel H.(Fig. 3). In addition, fewer superﬁcial blood vessels are apparent in the
heads of mutant embryos (Fig. 3A). These abnormalities, which were
100% penetrant, could be seen as early as E14.5 and the severity
increased with gestational age. In later stage null embryos (E18.5),
blood cells could be found in extravascular spaces around the spinal
cord. Several homozygous embryos also displayed signiﬁcant edema
on the back of the head overlying the 4th ventricle. Upon histological
Fig. 5. Hypoplastic thymus and thyroid and under mineralized and reduced sized skull
bones in Fbln1−/− embryos. Panel A, hypoplastic thymus and thyroid in a Fbln1−/−
embryo (E16.5) as compared with normal size thymus and thyroid glands in awild-type
embryo (+/+). Panel B, ventral view of Alizarin red/Alcian blue stained skulls from E17.5
embryos homozygous (−/−) and wild-type (+/+) for the Fbln1 gene trap insertion. Note
that the frontal (FB) and parietal bones (PB) of the null are membranous and show little
Alizarin red staining as compared to the same bones in the +/− skull, which are
extensively mineralized. Panel C, lower jaws from Fbln1−/− and Fbln1+/+ E17.5 embryos.
Note that the mandibles of the Fbln1 null embryos are smaller (micrognathia) than
those of the wild-type. Panel D, ear bones from Fbln1−/− and Fbln1+/+ E17.5 embryos.
Arrows in D point to the tympanic rings. Note that the tympanic ring in the mutant is
under mineralized and smaller than the control. L, larynx; M, malleus. Bars in panels B
and C=1 mm.
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blood vessels, which extend through the hyaloid cavity to the caudal
surface of the lens capsule, appear distended and the hyaloid cavity
appeared ﬁlled with blood cells (Figs. 3D and E).
The lungs of the Fbln1 null embryos (E17.5) appeared smaller than
normal. Histological analysis revealed that the lungs of homozygous
embryos have a greater cell density as compared to lungs of wild-type
or heterozygote embryos of the same gestational age (Supplementary
Fig. 3). Most notable is that lungs of Fbln1 nulls have few saccules.
Outﬂow tract abnormalities in Fbln1−/− embryos
Abnormalities of the remodeling of the OFT were evidenced by the
high incidence of double outlet right ventricle (DORV) (Fig. 4B and
Supplementary Figs. 4A–F) and overriding aorta in homozygotes
(Table 1). Persistent truncus arteriosus (PTA), resulting from a failure
of OFT septation, was not observed in Fbln1−/− embryos. Together,
these observations indicate that Fbln1 is not required for the septation
of the aorta and pulmonary artery, but that it is required for the proper
rotation of the aorta and pulmonary arteries during remodeling of the
OFT.
Cardiac septation defects in Fbln1−/− embryos
Ventricular septal defects (VSD) (both muscular and membranous)
were seen in 86% of the hearts from Fbln1−/− embryos (Fig. 4D,
Supplementary Figs. 4E and F and Table 1). The majority of these VSDs
(53%) occurred in combination with either DORV or overriding aorta.
Atrial septal defects (ASDs) were also observed in 40% (6 out of 15) of
Fbln1−/− hearts and included septum primum and septum secundum
anomalies (Supplementary Fig. 4G). The prevalence of VSD and ASD in
Fbln1−/− hearts emphasizes the important role of Fbln1 in proper
cardiac septation.
Aortic arch abnormalities in Fbln1−/− embryos
Abnormalities of morphology of the aortic arch arteries were
apparent in Fbln1 null embryos. The right subclavian artery (RSA),
which is derived from the right 4th-pharyngeal arch artery and
branches off the brachiocephalic artery was missing from its normal
position in 20% of the Fbln1−/− mutants (Fig. 4F). Moreover, in several
of these mutants, there was an anomalous blood vessel that emerged
from the aorta, caudal to the left subclavian, that passed behind the
esophagus (i.e., retroesophageal RSA). In addition, constrictions of the
right common carotid artery were also apparent in one Fbln1 null (Fig.
4H). These anomalies are consistent with defective remodeling of theTable 1
Penetrance of cardiac defects in embryos homozygous for gene trap disruption of the
ﬁbulin-1 gene
Cardiac/OFT anomaly No. of embryos displaying the anomaly Penetrance (%)
ASD 6 (n=15)1 40
VSD 5 (n=15)1 334
VSD with DORV 7 (n=15)1 474
VSD with OA 1 (n=15)1 74
ASD with DORV or OA 4 (n=15)1 27
Aortic Arch Defect2 3 (n=15)3 20
Thin Myocardium 6 (n=15)3 40
1Information was compiled from analysis of E15.5–18.5 null embryos. The background
of embryos homozygous for the Fbln1 gene trap insertion was 129P2/OlaHsd:C57BL/6
backcrossed to C57BL/6 for 2 generations.
2The principal aortic arch defects observed in Fbln1 nulls were an absence of the right
subclavian artery from its normal branch point from the brachiocephalic artery.
Abbreviations: ASD, atrial septal defects; VSD, ventricular septal defects; DORV, double-
outlet right ventricle; OA, overriding aorta.
3Information was compiled from analysis of 16.5–18.5 dpc null embryos.
4Eleven of 13 VSDs were membranous; 2 of 13 VSDs were muscular; and 2 of 13 VSDs
had both membranous and muscular defects.pharyngeal arch arteries, a process that requires proper NCC
investment into the arch artery sheath layers (Bockman et al., 1989).
Myocardial wall defects in Fbln1−/− embryos
In 40% of Fbln1−/− hearts (6 of 15 at E16.5–18.5), the compact layer
of the ventricular wall myocardium of both ventricles was thinner
compared to that of wild-type hearts (Supplementary Fig. 5).
Pharyngeal gland abnormalities in Fbln1−/− embryos
Examination of the pharyngeal glands of Fbln1-deﬁcient embryos
revealed a number of morphological abnormalities. In all Fbln1 null
embryos examined (E16.5–18.5, n=15), the thymus, which is derived
from the third pharyngeal pouch, was hypoplastic (Fig. 5A). Thymic
aplasia or uni-lobe thymus was not observed in null embryos. Fbln1−/−
embryos also displayed hypoplasia of the thyroid, which is derived
from the 3rd and 4th pharyngeal arches and pouches (Fig. 5A).
Craniofacial skeletal abnormalities in Fbln1−/− embryos
Analysis of the ossiﬁed and cartilaginous tissues of the craniofacial
skeleton of Fbln1 mutant embryos (E17.5) revealed decreased
ossiﬁcation of most cranial bones, particularly the frontal, parietal,
tympanic ring, nasal and premaxillary bones (Figs. 5B–D). There was
also reduction in the size ofmany skull bones in the nulls including the
mandible (micrognathia) (Fig. 5C) and tympanic ringbones (Fig. 5D) as
well as an overall reduced cranial size as compared to littermate
controls. No cleft palate was observed in the Fbln1 nulls. The neural
crest-derived elements of the cartilages of the throat (i.e., hyoid and
thyroid) also appear reduced in the nulls as compared to wild-type
embryos (data not shown).
Fbln1 expression in the neural crest, somites, pharyngeal arches and
distal OFT/secondary heart ﬁeld
As a result of the gene trapping, β-gal is placed under the control of
the Fbln1 promoter. X-gal staining was performed to establish the
pattern of Fbln1 expression in heterozygous embryos. X-gal staining
was apparent in presomitic mesoderm from E8.75 to E9.0 (Figs. 6A–D).
Fig. 6. Fbln1 expression in the neural crest, somites, secondary heart ﬁeld and pharyngeal arches. Panels A–E are dorsal and lateral views of X-gal stained embryos heterozygous for
the Fbln1 gene trap insertion at E8.75 (A and B), E9.0 (C and D) and E10.5 (E). Arrowheads in panels A and C indicate X-gal-positive cells in neural folds and dorsal neural tube regions.
White brackets in panels B and D indicate X-gal staining in presumptive secondary heart ﬁeld regions. PSM, presomitic mesoderm; Ot, otic vesicle; p1, p2 and p3 indicate pharyngeal
arches 1, 2 and 3. Bars in panels A and B=250 μm. Bar in E=300 μm.
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6A–E). X-gal staining was also apparent along the margins of neural
folds in caudal regions of the embryo and dorsal regions of the neural
tube (Figs. 6A and C, arrowheads). At E10.5, the dorsal neural tube
region was relatively free of X-gal stained cells, however, pronounced
X-gal staining was apparent in populations of cells lateral to the
hindbrain, around the otic vesicle, in pharyngeal arches 1–3, in
anterior and posterior regions of the somites, in the limb buds and in
the region of the cardiac inﬂow tract (Fig. 6E).
Consistent with the X-gal staining, immunohistological analysis
showed pronounced Fbln1 immunolabeling in the ECM of the
mesenchyme lateral to the neural tube at the level of the pharyngeal
arches in E9.5–10.5 embryos (Figs. 7A and B). By contrast, relatively
low levels of Fbln1 immunolabeling were detected in the arch
mesenchyme directly adjacent to the aortic sac/distal OFT (Figs. 7A
and B, brackets). At E9.5, this area was rich in Pax3-expressing NCCs
(Fig. 7C, brackets). Prominent Fbln1 labeling was evident in the ECM of
the distal OFT, in the region of the SHF (Figs. 7C and D, arrowheads).
Pharyngeal arch mesenchyme underlying the neural tube had high
levels of Fbln1 and few Pax3-positive cells (Fig. 7C, asterisk). Little or
no Fbln1 labeling was apparent in pharyngeal arch ectoderm or
endoderm at E9.5–10.5.
Whole-mount in situ RNA hybridization analysis of wild-type
E8.3–9.5 embryos showed that Fbln1mRNA is expressed in presomitic
mesoderm and somites, similar to what was observed in X-gal stained
embryos heterozygous for the gene trap insertion (Fig. 8). Fbln1 RNA
was also detected in rhombomeres 2, 4, 6/7 and in pharyngeal arches
1–4 (Figs. 8C and D). The rhombomere expression of Fbln1 is similar to
that of the NCC marker Crabp1 (Fig. 8E). Together, the ﬁndings from
Fbln1 expression analysis indicate that Fbln1 expression is associated
with migratory pathways of NCCs derived from rhombomeres 2–7,
which contribute to morphogenesis of the OFT and pharyngeal glands.Fig. 7. Fbln1 expression in the headmesenchyme and secondary heart ﬁeld. Panels A and B sh
to Fbln1 and αSM actin (SMA). C, sagittal section of a wild-type E9.5 embryo immunolabeled
E10.5 embryo immunolabeled with antibodies to Fbln1. Arrowheads point to Fbln1 staining in
subendothelial ECM of the 4th aortic arch artery. Bracketed areas in Panels A and B conta
Bracketed area in panel C indicates the region of pharyngeal arch 3/4 that contains streams
pharynx; AS, aortic sac; Ot, otic vesicle; A, atrium; V, ventricle; OFT, outﬂow tract; p1 and p2
D=300 μm.However, it is not known whether Fbln1 is expressed by migrating
NCCs or by non-neural crest derived-mesenchymal cells located along
the path of migrating NCCs.
Fbln1 gene trap nulls have cranial nerve patterning abnormalities
NCCs derived from rhombomeres 2, 4, 6 and 7 also contribute to the
formation of the cranial nerves. In situ hybridization analysis using a
Sox-10 probe revealed abnormalities in the patterning of cranial nerve
NCCs in Fbln1 null embryos (Figs. 9A–C). In particular, interruptions and
inappropriately directed streams of Sox-10-positive NCCs that comprise
the primordia for cranial nerves IX (glossopharyngeal) and X (vagus)
were observed (Figs. 9B and C). The apparent misguidance of NCCs
resulted in abnormal mixing of the distal regions of the glossophar-
yngeal and vagal streams (Figs. 9B and C, brackets), which may be
interpreted to have resulted from a caudal misdirection of the glosso-
pharyngeal stream. Abnormal branching of the proximal region of the
vagal streamwas also observed in some embryos (data not shown).
To evaluate the impact of Fbln1 deﬁciency on cranial nerves, E10.5
embryos were immunostained to detect neuroﬁlament-M. The results
reveal abnormalities in cranial nerves IX and X (Figs. 9D–F). Null
embryos displayed an interruption in the proximal portion of cranial
nerve IX and a less than normal degree of branching in the distal
segment (Figs. 9E and F). Furthermore, there was an abnormal fusion
of cranial nerves IX and X in the epibranchial placode region (Fig. 9E).
Cranial nerve X in Fbln1 null embryos also appeared more compact
and less reticulated than in wild-type embryos (Figs. 9E and F).
Fbln1 gene trap nulls have increased apoptosis of NCCs in the hindbrain
TUNEL analysis was performed to assess the consequence of Fbln1
deﬁciency on NCC survival. Null E10.5 embryos displayed increasedow cross sections of a wild-type E9.5 and E10.5 embryo immunolabeled with antibodies
with antibodies to Fbln1 and Pax3, a NCCmarker. Panel D, sagittal section of a wild-type
the secondary heart ﬁeld (SHF) region. Arrow in panel B points to Fbln1 staining in the
in pharyngeal arch regions displaying relatively low levels of Fbln1 immunolabeling.
of Pax3-positive cells emanating from rhombomere 6 and 7 (r6/7). NT, neural tube; P,
indicate pharyngeal arches 1 and 2. Bars in panels A and C=150 μm. Bars in panels B and
Fig. 8. Fbln1 in situ RNA hybridization analysis. Shown are wild-type embryos (E8.3–9.5) after whole mount in situ hybridization with antisense riboprobes for Fbln1 (A–D) and
Crabp1 (E), a marker of migrating NCCs. S, somite; psm, presomitic mesoderm; cpm, cranial paraxial mesoderm; r2, r4, r6 indicate rhombomeres 2, 4 and 6; p1, p2 and p3 indicate
pharyngeal arches 1, 2 and 3. Bars in panels A–E=200 μm.
342 M.A. Cooley et al. / Developmental Biology 319 (2008) 336–345levels of TUNEL-positive cells in the hindbrain region as compared to
wild-type embryos (Figs. 9G and H). In particular, relatively high levels
of TUNEL-positive cells were apparent in the otic vesicle epithelium
and around rhombomeres 4, 6 and 7 as compared to wild-type
embryos. To determine if the apoptotic cells observed in Fbln1 nullsFig. 9. Fbln1 deﬁciency leads to anomalies of cranial NCC patterning and cranial nerve
morphogenesis as well as increased apoptosis in hindbrain regions. Panels A–C, lateral
views of E10.5 Fbln1+/+ (A) and Fbln1−/− embryos (B and C) after whole mount in situ
hybridization with antisense riboprobe for Sox-10, a transcription factor expressed by
migratory NCCs that form the cranial nerves. Arrows in panels A–C indicate the forming
glossopharyngeal and vagus nerves (cranial nerves IX and X). Note the decreased level
of Sox-10 expression in the forming glossopharyngeal nerves (white arrowheads in
panels B and C). Abnormal fusion of glossopharyngeal ganglia with the distal ganglia of
cranial nerve X is apparent in the nulls (brackets in panels B and C). In the embryo shown
in panels C, cranial nerve X has a decreased level of Sox-10 expression relative to the
control. The results depicted in panels A–C are representative of in situ hybridizations
from 3 sets of embryos. Panels D–F, lateral views of wild-type (D) and Fbln1−/− (E and F)
E10.5 embryos with cranial nerves immunolabeled with monoclonal neuroﬁlament-M
antibody. Brackets labeled a in panels D–F indicate the proximal portion of the cranial
nerve IX, which is hypoplastic and absent in the Fbln1 null embryos shown in panels E
and panels F, respectively. White arrowheads in panels E and F indicate bridging in the
epibranchial placode-derived regions of cranial nerves IX and X. Panels G and H,
confocal images of sagittal sections from E10.5 Fbln1+/+ and Fbln1−/− embryos assayed
for apoptosis (TUNEL, green). Nuclei were stained with propidium iodide (red). Panels I
shows an anti-Crabp1 immunolabeled (green) adjacent section of the Fbln1 null embryo
shown in panel H. p1, p2 and p3 indicate pharyngeal arches 1, 2 and 3; r4, r6 and r7
indicate rhombomeres 4, 6 and 7. Ot, otic vesicle. Bar in panel A=300 μm and applies to
panels A–C. Bar in panel D=300 μm and applies to panels D–F. Bar in panel G=100 μm
and applies to panels G–I.might correspond to NCCs, immunolabeling was performed using
antibodies to the NCC marker, Crabp1. Crabp1-positive cells were
observed in null embryos in streams extending from rhombomeres 4,
6 and 7, which corresponded to areas having high levels of TUNEL-
positive cells (Fig. 9I).
Genetic background inﬂuences penetrance of cardiac anomalies in Fbln1
nulls
While the bleeding, lung abnormalities and perinatal lethality in
Fbln1 gene trap homozygotes are in agreement with an earlier
analysis of mouse Fbln1 deﬁciency (Kostka et al., 2001), abnormalities
of the OFT, arch arteries, pharyngeal glands, cranial nerves and
cephalic skeleton were not previously reported. Differences in genetic
background could account for the phenotypic disparities given that
the Fbln1 gene trap homozygotes were a mixed C57BL/6 and 129P2/
OlaHsd background whereas embryos homozygous for Fbln1 exon 1
deletion were a mixed C57BL/6 and 129/Sv background (Kostka et al.,
2001). When we examined embryos homozygous for the Fbln1 exon 1
deletion we found hypoplastic thymus (100% penetrance) as well as
cardiac defects corresponding to those observed in embryos homo-
zygous for the Fbln1 gene trap mutation (e.g., VSD associated with
DORV) (Supplementary Fig. 6). However, the penetrance of cardiac
defects in the Fbln1 exon 1 mutants was lower than that of the Fbln1Table 2
Inﬂuence of background on penetrance of cardiac defects in embryos homozygous for




















ASD 40 23 14 44
VSD 33 38 0 22
VSD with
DORV




7 8 0 22
1The background of embryos homozygous for the Fbln1 gene trap insertion was 129P2/
OlaHsd:C57BL/6 backcrossed to C57BL/6 for 2 generations. Percentages indicated are
based on evaluation of 15 embryos homozygous for the Fbln1 gene trap insertion.
2The background of embryos homozygous for the Fbln1 gene trap insertion was 129P2/
OlaHsd:C57BL/6 backcrossed to C57BL/6 for 5 generations. Percentages indicated are
based on evaluation of 13 embryos (E15.5–18.5) homozygous for the Fbln1 gene trap
insertion.
3The background of the mouse containing the Fbln1 exon 1 deletion was 129/Sv:C57BL/
6 backcrossed to C57BL/6 for indeterminate number of generations. We subsequently
backcrossed it to C57BL/6 for 2 generations. Percentages indicated are based on
evaluation of 14 embryos (E15.5–18.5) homozygous for the Fbln1 exon 1 deletion.
4Percentages indicated are based on evaluation of 9 embryos (E15.5–18.5) each having
one Fbln1 allele carrying the Fbln1 gene trap insertion (129P2/OlaHsd:C57BL/6
background as described in column 1) and the other Fbln1 allele carrying the Fbln1
exon 1 deletion (C57BL/6 background as described in column 3). Note that all embryos
of this genotype displayed thymic hypoplasia.
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of cardiac defects in the Fbln1 gene trap could be affected by the
genetic background. When the Fbln1 gene trap line was backcrossed
further onto a C57BL6 background the penetrance of cardiac defects
was reduced to levels comparable with the Fbln1 exon 1 deletion on a
mixed C57BL/6 and 129/Sv background. Fbln1-deﬁcient embryos were
also generated by mating the Fbln1 gene trap strain (mixed C57BL/6
and 129P2/OlaHsd background) to the Fbln1 exon 1 deletion strain
(C57BL/6 and 129/Sv background). As shown in Table 2, the hybrids
displayed a level of penetrance higher than the Fbln1 exon 1 deletion
homozygotes having the mixed C57BL/6 and 129/Sv background.
These ﬁndings suggest that the severity of cardiac defects in embryos
deﬁcient in Fbln1 is increased by genetic modiﬁers found within
the129P2/OlaHsd background.
Discussion
Collectively, the newly revealed malformations of Fbln1-deﬁcient
embryos are similar to congenital defects known as neurocristopa-
thies, which result from defective NCC development. Indeed, with the
exception of an absence of OFT septation defects in Fbln1 nulls, the
spectrum of malformations observed in the nulls are similar to those
that result from ablation of the cephalic premigratory neural crest
(Bockman and Kirby, 1984; Bockman et al., 1987; Hutson and Kirby,
2003). For example, neural crest ablation is associated with aplasticity
or hypoplasticity of the thymus, parathyroid and thyroid glands and a
failure of aortic arch arteries three, four and six to develop (Bockman
and Kirby, 1984; Bockman et al., 1987). Fbln1 mutants display
hypoplasia of the thymus and thyroid and anomalies of aortic arch
arteries. Thus, the anomalies observed in the Fbln1 nulls are con-
sistent with an insufﬁciency in numbers of speciﬁc populations of
NCCs. Our ﬁnding that Fbln1 nulls have increased apoptosis in
hindbrain regions that contain NCC populations migrating into the
pharyngeal arches suggests that reduced NCC survival may be a
contributing factor to NCC insufﬁciency. The bleeding that occurs
primarily in the head and neck regions of Fbln1 deﬁcient embryosmay
also represent a neurocristopathy since cephalic NCCs contribute
pericytes and vascular smooth muscle cells to all of the blood vessels
of the head including pericytes of the hyaloid vasculature (Etchevers
et al., 2001; Gage et al., 2005; Korn et al., 2002). Even the lung
abnormalities observed in the Fbln1 nulls might be neural crest re-
lated given the fact that vagal NCCs colonize the developing lung buds
(Burns et al., 2008).
NCCs also inﬂuence the contribution of cells to the heart from the
SHF, a region of pharyngeal arch mesenchyme that underlies the
caudal pharynx and surrounds the aortic sac (Mjaatvedt et al., 2001;
Waldo et al., 2001; Yelbuz et al., 2002). When premigratory neural
crest is ablated, insufﬁcient addition of myocardial progentitors from
the SHF is believed to be the basis for the incomplete rotation of the
aorticopulmonary septum and incorrect ventriculoarterial alignment
(i.e., overriding aorta and DORV) (Yelbuz et al., 2002). Fbln1 nulls
display both DORV and overriding aorta. The SHF also contributes
cells to the right ventricular myocardium and interventricular
septum (Verzi et al., 2005). Fbln1 mutant hearts show thinning of
the right ventricular myocardium as well as interventricular septal
defects (e.g., muscular VSD). The DORV, overriding aorta, thin
myocardium and VSDs together with the ﬁnding that Fbln1 is ex-
pressed in the SHF region suggest that Fbln1 inﬂuences the indirect
roles of NCCs in promoting addition of myocardium from the SHF to
the OFT, right ventricle and interventricular septum. However, it
cannot be ruled out that the thin ventricular myocardium and mem-
branous VSDs observed in Fbln1 nulls might be related to anomalies
of non-NCC mesenchymalization (Kirby, 2002) given that Fbln1
expression is associated with epithelial-mesenchymal transition of
the epicardium (WSA, unpublished observation) and AV cushions
(Kern et al., 2006).Cardiac neural crest ablation is also associated with an absence or
poor development of cranial nerves IX and X (Kuratani et al., 1991).
The IXth cranial nerve, the glossopharyngeal nerve, derives fromNCCs
of rhombomere 6 and innervates the third pharyngeal arch (D'Amico-
Martel and Noden, 1983). The Xth cranial nerve, the vagus nerve,
derives from NCCs of rhombomere 7 and innervates the 4th
pharyngeal arch. In Fbln1 nulls, hypoplasticity and patterning
anomalies of the NCC precursors for these cranial nerves is observed
in E10.5 embryos as revealed by Sox-10 in situ hybridizations. The
patterning anomalies include interruptions and apparent misgui-
dance in the streams of Sox-10-positive NCCs that comprise each
nerve primordia. The apparent misguidance is manifested by
abnormal mixing of the distal regions of the glossopharyngeal and
vagal streams of Sox-10-positive NCCs. These abnormalities in Sox-10-
expressing NCCs aremirrored by abnormalities in the cranial nerves of
Fbln1 nulls as revealed by neuroﬁlament-M immunolabeling. Speci-
ﬁcally, the proximal portion of cranial nerve IX in nulls was missing
and the distal epibranchial placode-derived region was often fused
with the vagus nerve. Given the evidence that post otic rhombomere-
derived NCCs (i.e., rhombomere 6–7 Sox-10-positive cells) contribute
to the heart (Montero et al., 2002), the observed abnormalities in
rhombomere 6–7 NCC patterning might also be a contributing factor
to the OFT defects in Fbln1 nulls.
Abnormalities in Fbln1 nulls, including patterning defects of
cranial nerves IX and X, are also seen in Hoxa3 null mice (Chisaka
and Capecchi, 1991). Like the Fbln1 nulls, mice deﬁcient in Hoxa3 die
at or shortly after birth and display hypoplastic thymus and thyroid
(Chisaka and Capecchi, 1991). Hoxa3 nulls also display arch artery and
heart abnormalities resembling those seen in Fbln1 nulls (Chisaka and
Capecchi, 1991). Hoxa3 is expressed in rhombomeres 5–8, which
contribute NCCs to the formation of cranial nerves IX–XII. In Hoxa3
nulls, the formation of cranial nerves IX and X is affected in a manner
similar to that seen in Fbln1 nulls, with a fusion of the epibranchial
placode regions of the two nerves and a gap in the proximal portion of
IX (Watari et al., 2001). Evidence that cranial nerve anomalies in
Hoxa3 nulls are a consequence of NCCs defects comes from the ﬁnding
of reduced Sox-10-positive cells in streams emanating from rhombo-
meres 6/7 (Watari et al., 2001). Again, these ﬁndings are consistent
with our results showing an apparent reduction in the level of Sox-10
expression in the stream of NCCs that comprise the primordia for
cranial nerve IX as well as a mixing of Sox-10 positive cells in distal
regions of the glossopharyngeal and vagal streams.
An underlying basis for the mixing and interruptions of NCC
streams emanating from rhombomeres 6 and 7 seen in Fbln1 nulls
may be defects in NCC motility and guidance. Defective migration of
Sox-10-positive NCCs emanating from rhombomeres 6 and 7 has been
implicated in cranial nerve IX interruptions observed in mice deﬁcient
in Hoxa3 (Watari et al., 2001). Migration defects of rhombomere 6–7-
derived, Sox-10-positive NCCs have also been speculated to account
for the gap in glossopharyngeal nerves observed in mice doubly
deﬁcient for the Nk-related homeodomain transcription factors Msx1
and Msx2 (Ishii et al., 2005). Additional evidence for NCCs of Msx1/
Msx2 double mutants having migration problems comes from the
ﬁnding of Sox-10-positive NCCs in the normally NCC-free zone of
rhombomere 3 (Ishii et al., 2005). As a result of this apparent
misguidance/unrestrictedmigration, there is a fusion of the trigeminal
and facial cranial nerves. Indeed, in Fbln1 nulls we observed Sox-10-
positve cells in the normally NCC-free zone between the glossophar-
yngeal and vagal NCCs streams and a subsequent fusion of the two
nerves. These ﬁndings are consistent with the known roles of Fbln1 as
a suppressor of motility (Hayashido et al., 1998; Lee et al., 2005; Qing
et al., 1997; Twal et al., 2001) and a regulator of directed cell migration
(Kubota et al., 2004).
The abnormalities of Fbln1 nulls are similar to the constellation of
congenital malformations of the aortic arch, heart, thymus, thyroid
and bones of the head that are associated with DiGeorge syndrome
344 M.A. Cooley et al. / Developmental Biology 319 (2008) 336–345(DGS) (Baldini, 2004; Liao et al., 2004). The majority of DGS
individuals are heterozygous for a microdeletion of human chromo-
some 22q11.2; however, the remaining individuals do not possess a
22q11.2 deletion indicating that mutation of genes outside of the
region may cause the disorder. The Fbln1 gene is located outside of the
22q11.2 deletion region at 22q13.3 (Korenberg et al., 1995). Since
heterozygous deletion of Fbln1 in mice did not lead to OFT, aortic arch,
cardiac, pharyngeal gland or craniofacial anomalies, Fbln1 haploin-
sufﬁciency does not lead to the same outcome as occurs with
haploinsufﬁciency of genes located within the 22q11.2 deletion
region. The variable penetrance and severity of DGS also indicate
that genes from outside of the microdeletion region may act as
modiﬁers of the DGS pathogenesis pathway. Several candidate DGS
modiﬁer genes have been identiﬁed through gene deletion studies in
mice. For example, Hoxa3 deﬁciency in mice leads to a DGS-like
phenotype (Chisaka and Capecchi, 1991). In addition, Fgf8, and Gbx2,
an Fgf8-inducible transcription factor (Liu and Joyner, 2001), when
deleted individually or in combination in mice leads to cardiac, aortic
arch artery and craniofacial anomalies consistent with features of
22q11 deletion in humans (Abu-Issa et al., 2002; Byrd and Meyers,
2005; Frank et al., 2002).
The similarities that exist between the DGS phenotype and that of
Fbln1-deﬁcient embryos raises the possibility that Fbln1 has links to
the mechanism by which 22q11 deletion causes DGS pathogenesis.
Interaction with the Fgf8 signaling pathway represents one plausible
mechanism. Fgf8 signaling is mediated by Fgfr1 and 2 interactionwith
the adaptor protein, Crkl (Moon et al., 2006), whose deﬁciency in mice
causes many of the anomalies seen in DGS (Guris et al., 2001) and in
Fbln1 nulls. Mechanistically, Crkl participates in activation of the Raf-
1/MEK/Erk signaling pathway (Arai et al., 2006) and mediates FN-
integrin-induced cell migration (Li et al., 2003) and cell survival.
Indeed, Crkl deﬁciency in mice leads to decreased survival of NCCs
that contribute to the pharyngeal arches and OFT (Moon et al., 2006),
an outcome similar to what is observed in the Fbln1 nulls. Although
Fbln1 is not known to interact with Fgf8, Fbln1 does regulate Erk
activation and FN-induced cell migration (Twal et al., 2001). Future
studies will need to test this and other possible interactions between
Fbln1 and the repertoire of genes associated with DGS.
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